Literature DB >> 30784659

The elusive podocyte crossmatch for recurrent focal segmental glomerulosclerosis.

George W Burke1, Alessia Fornoni2.   

Abstract

Focal segmental glomerulosclerosis is a glomerular disorder with a high rate of recurrence. Although kidney biopsies remain the gold standard to diagnose recurrent focal segmental glomerulosclerosis, non-invasive prognostic assays could facilitate preventive treatments and offer insight into disease pathogenicity and heterogeneity. Srivastava et al. describe a simple, cell-based assay to predict recurrence of focal segmental glomerulosclerosis. Although the study needs to be optimized and validated, its novelty is that it does not depend on the specificity of a given permeability factor.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 30784659     DOI: 10.1016/j.kint.2018.11.032

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  2 in total

1.  Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal.

Authors:  George W Burke; Jayanthi Chandar; Junichiro Sageshima; Mariella Ortigosa-Goggins; Pooja Amarapurkar; Alla Mitrofanova; Marissa J Defreitas; Chryso P Katsoufis; Wacharee Seeherunvong; Alexandra Centeno; Javier Pagan; Lumen A Mendez-Castaner; Adela D Mattiazzi; Warren L Kupin; Giselle Guerra; Linda J Chen; Mahmoud Morsi; Jose M G Figueiro; Rodrigo Vianna; Carolyn L Abitbol; David Roth; Alessia Fornoni; Phillip Ruiz; Gaetano Ciancio; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2022-05-04       Impact factor: 3.714

2.  Amount and selectivity of proteinuria may predict the treatment response in post-transplant recurrence of focal segmental glomerulosclerosis: a single-center retrospective study.

Authors:  Hideki Ban; Kenichiro Miura; Naoto Kaneko; Yoko Shirai; Tomoo Yabuuchi; Kiyonobu Ishizuka; Hiroko Chikamoto; Yuko Akioka; Satoru Shimizu; Hideki Ishida; Kazunari Tanabe; Motoshi Hattori
Journal:  Pediatr Nephrol       Date:  2021-02-04       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.